Cutaneous squamous cell carcinoma is the second most common type of skin cancer in the United States, impacting approximately 700,000 people each year. While medications exist to prevent the development of disease, they are ...
Oct 11, 2023
0
24
An international research team led by Hong Kong University of Science and Technology (HKUST) has unveiled how primary brain tumors evolve under therapy, and has developed an artificial intelligence (AI)-powered model for ...
Oct 10, 2023
0
5
Researchers from the Nuffield Department of Clinical Neurosciences at the University of Oxford, along with colleagues at Cambridge University and Barts and the London School of Medicine and Dentistry, have shown the potential ...
Oct 5, 2023
0
61
What if a vaccine, given to patients just before or after arriving at the hospital, could protect them against lethal superbugs that lurk in health care settings?
Oct 4, 2023
0
32
A research paper published in Science Translational Medicine presents a significant breakthrough in the area of skin regeneration and wound healing by researchers at the Wake Forest Institute for Regenerative Medicine (WFIRM).
Oct 4, 2023
0
74
New tests of a recently approved vaccine for respiratory syncytial virus—RSV—show the shot remains effective against a range of variants producing potent antibody responses against current and past strains, and may even ...
A severe form of fatty liver disease called nonalcoholic steatohepatitis (NASH) is the leading cause of liver transplantation, but there are few treatment options and currently no medications. In a new study, Yale researchers ...
Sep 27, 2023
0
85
Researchers at ETH Zurich have developed a suction cup that allows medications to be absorbed through the mucosal lining of the cheeks. This new approach could spare millions of patients the pain and fear associated with ...
Sep 27, 2023
0
13
It is an all-too-common fact that potential drugs can look extremely promising in preclinical laboratory testing but fail when it comes to effectively treating humans. To better translate promising lab findings into effective ...
Sep 20, 2023
0
23
Giant cell arteritis (GCA), formerly known as temporal arteritis, was first described by Mayo Clinic doctors and classified as an inflammatory condition of the blood vessels in the early to mid-20th century. The condition ...
Sep 18, 2023
0
29
